Skip to main content

Not Found
On Demand

Total Credits: 1 including 1 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
Faculty:
Jolene Smith, DO
Price:
$40.00 - Base Price

Not Found
On Demand

Total Credits: .5 including .5 AOA Category 1-A Credit(s)

Average Rating:
   10
Faculty:
Dr. Ryan Garbalosa, D.O.
Short Description:
The COVID-19 pandemic has had global implications and can impact several organ systems. This talk will cover the possible cardiovascular complications that may be encountered as a result of infection.
Price:
$30.00 - Base Price

Not Found
On Demand

Total Credits: 1 including 1 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
Faculty:
Scott Ewing, DO
Price:
$40.00 - Base Price

Not Found
On Demand

Total Credits: 1 including 1 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
Faculty:
Dmitry Blumenkrants, M.D.
Price:
$40.00 - Base Price

Not Found
On Demand

Total Credits: .75 including .75 AOA Category 1-A Credit(s)

Average Rating:
   8
Faculty:
Jeremy Warner, DO
Short Description:
First presented at the 2020 OPSO Conference (9/18/2020) OPSO is pleased to offer this CME program on-demand. In this program Jeremy Warner, DO presents Cardiac Stress Testing: Some Useful Considerations
Price:
$26.25 - $33.75

Not Found
On Demand

Total Credits: 1 including 1 AOA Category 1-A Credit(s)

Average Rating:
   45
Faculty:
Kayvan Amini, DO, FACC
Short Description:
Kayvan Amini, DO, FACC shares his expertise in the cardiology update 2023
Price:
$40.00 - Base Price

Not Found
On Demand

Total Credits: .75 including .75 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
Faculty:
William Elliott, M.D. Ph.D.
Short Description:
Physicians and medical professionals will learn why long-term randomized clinical trials against placebo were done to verify the cardiovascular safety of novel hypoglycemic agents. They will compare and contrast outcomes in randomized clinical trials for sodium-glucose-linked transporter-2 inhibitors, glucagon-like peptide-1 agonists, and dipeptidyl peptidase-4 inhibitors for cardiovascular or renal endpoints. They will be able to name the pharmacological agents (and their indications) that have received FDA approval for "benefits beyond glucose-lowering" with regard to preventing cardiovascular or renal endpoints.
Price:
$30.00 - Base Price

Not Found
On Demand

Total Credits: .75 including .75 AOA Category 1-A Credit(s)

Average Rating:
   11
Faculty:
Ben Hudson, DO
Short Description:
First presented at the OPSO 2020 conference (9/19/2020) OPSO is pleased to offer this CME program on-demand. In this program Ben Hudson, DO discusses possible complications of COVID-19 in patients with cardiovascular disease.
Price:
$26.25 - $33.75

Not Found
On Demand

Total Credits: .75 including .75 AOA Category 1-A Credit(s)

Average Rating:
   397
Faculty:
Sepideh Darbandi, DO
Price:
$30.00 - Base Price

Not Found
On Demand

Total Credits: .75 including .75 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
Faculty:
George P. Gabriel, DO
Price:
$30.00 - Base Price

Please wait ...

Back to Top